Currently, all soft tissue sarcomas (STS) are irradiated by the same regimen, disregarding possible subtype-specific radiosensitivities. To gain further insight, cellular radiosensitivity was investigated in a panel of sarcoma cell lines. Fourteen sarcoma cell lines, derived from synovial sarcoma, leiomyosarcoma, fibrosarcoma and liposarcoma origin, were submitted to clonogenic survival assays. Cells were irradiated with single doses from 1-8 Gy and surviving fraction (SF) was calculated from the resulting response data. Alpha/beta (alpha/beta) ratios were inferred from radiation-response curves using the linear-quadratic (LQ)-model. Cellular radiosensitivities varied largely in this panel, indicating a considerable degree of heterogeneity....
Sarcomas are heterogeneous and clinically challenging soft tissue and bone cancers. Although constit...
Soft tissue sarcomas (STS) are a rare group of mesenchymal solid tumors with heterogeneous genetic p...
Soft-tissue sarcomas are rare diseases with >50 subtypes. Surgery is the most important treatment in...
Background: Soft-tissue sarcomas (STS) are heterogeneous with variable response to radiation therapy...
Background/Purpose: Local and systemic control of soft tissue sarcoma (STS) remains a clinical chall...
Soft tissue sarcoma (STS) is a rare cancer that develops from soft tissues in any part of the body. ...
Background: Given the rapid evolution in the management of soft tissue sarcoma (STS), it is essentia...
Background: Soft-tissue sarcomas (STS) are a diverse group of malignancies that remain a diagnostic ...
Soft tissue sarcomas (STSs) are malignant tumors of mesenchymal origin, characterized by an extreme ...
International audienceBackground: Evaluation of response to neoadjuvant radiotherapy (NART) does not...
International audienceBackground: Evaluation of response to neoadjuvant radiotherapy (NART) does not...
Background: Given the rapid evolution in the management of soft tissue sarcoma (STS), it is essentia...
Soft tissue sarcomas (STS) are a rare group of mesenchymal solid tumors with heterogeneous genetic p...
Podium Presentations. Podium No: 362Lower levels of ionizing radiation may be associated with the ri...
SUMMARY-Sarcoma-specific cellular cytotoxicity was evaluated in patients with skeletal and soft-tiss...
Sarcomas are heterogeneous and clinically challenging soft tissue and bone cancers. Although constit...
Soft tissue sarcomas (STS) are a rare group of mesenchymal solid tumors with heterogeneous genetic p...
Soft-tissue sarcomas are rare diseases with >50 subtypes. Surgery is the most important treatment in...
Background: Soft-tissue sarcomas (STS) are heterogeneous with variable response to radiation therapy...
Background/Purpose: Local and systemic control of soft tissue sarcoma (STS) remains a clinical chall...
Soft tissue sarcoma (STS) is a rare cancer that develops from soft tissues in any part of the body. ...
Background: Given the rapid evolution in the management of soft tissue sarcoma (STS), it is essentia...
Background: Soft-tissue sarcomas (STS) are a diverse group of malignancies that remain a diagnostic ...
Soft tissue sarcomas (STSs) are malignant tumors of mesenchymal origin, characterized by an extreme ...
International audienceBackground: Evaluation of response to neoadjuvant radiotherapy (NART) does not...
International audienceBackground: Evaluation of response to neoadjuvant radiotherapy (NART) does not...
Background: Given the rapid evolution in the management of soft tissue sarcoma (STS), it is essentia...
Soft tissue sarcomas (STS) are a rare group of mesenchymal solid tumors with heterogeneous genetic p...
Podium Presentations. Podium No: 362Lower levels of ionizing radiation may be associated with the ri...
SUMMARY-Sarcoma-specific cellular cytotoxicity was evaluated in patients with skeletal and soft-tiss...
Sarcomas are heterogeneous and clinically challenging soft tissue and bone cancers. Although constit...
Soft tissue sarcomas (STS) are a rare group of mesenchymal solid tumors with heterogeneous genetic p...
Soft-tissue sarcomas are rare diseases with >50 subtypes. Surgery is the most important treatment in...